share_log
Reuters ·  Mar 13 11:09
Shanghai Fosun Pharma - Unit Got Approval for Clinical Trial of Xh-S003 Capsules From Nmpa China
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 202

Recommended

Write a comment